Weiming Xu, MD., Ph.D
Senior Medical Director @ Sarah Cannon Research Institute
About
An experienced hematologist/oncologist with a proven track record in clinical development, I bring expertise in strategic planning, trial design, protocol development, medical monitoring, pharmacovigilance, and end-to-end trial management across all phases of oncology studies. I have contributed to numerous Phase I–III clinical trials in both hematologic malignancies and solid tumors and am well-positioned to provide scientific leadership in advancing innovative therapies.
United States
San Diego
Pharmaceuticals
Clinical Development, Oncology, Drug Discovery, Good Clinical Practice (GCP), Hematology, Pharmacovigilance, Immunology, Clinical Trials, Medical Monitoring, Phase I, Biomarkers, Clinical Strategy, Drug Development, In Vitro, Inflammation, Pharmaceutical Industry, Assay Development, Cancer
Experience

Senior Medical Director
SCRI is a global leader in oncology research, conducting clinical trials in the community for more than 30 years. The research network brings together more than 1,300 physicians who are actively enrolling patients to clinical trials at more than 250 locations in 24 states across the U.S.
Weiming Xu, MD., Ph.D's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.










